|
MON1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.382500E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.450100E-02 |
| Normal-vs-Stage2 |
1.099560E-01 |
| Normal-vs-Stage3 |
4.211900E-02 |
| Normal-vs-Stage4 |
6.409800E-02 |
| Stage1-vs-Stage2 |
3.087000E-01 |
| Stage1-vs-Stage3 |
1.661570E-01 |
| Stage1-vs-Stage4 |
1.403880E-02 |
| Stage2-vs-Stage3 |
8.897800E-01 |
| Stage2-vs-Stage4 |
2.797900E-02 |
| Stage3-vs-Stage4 |
8.935900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.767700E-04 |
| Normal-vs-AfricanAmerican |
5.117800E-01 |
| Normal-vs-Asian |
5.685600E-01 |
| Caucasian-vs-AfricanAmerican |
4.317700E-02 |
| Caucasian-vs-Asian |
7.721200E-01 |
| AfricanAmerican-vs-Asian |
7.053000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.900800E-03 |
| Normal-vs-Female |
1.517600E-03 |
| Male-vs-Female |
9.100500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.255600E-01 |
| Normal-vs-Extreme_Weight |
3.335800E-01 |
| Normal-vs-Obese |
4.384700E-03 |
| Normal-vs-Extreme_Obese |
6.004000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.492800E-01 |
| Normal_Weight-vs-Obese |
2.426100E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.693600E-01 |
| Extreme_Weight-vs-Obese |
5.130100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.671200E-01 |
| Obese-vs-Extreme_Obese |
4.408000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.966000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.045600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.840190E-02 |
| Normal-vs-Age(81-100Yrs) |
8.732200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.475000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.080600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.360800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.279000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.818700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.700100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.364340E-03 |
| Normal-VS-Type2 PRCC |
3.138200E-01 |
| Normal-VS-KIRP CIMP |
2.185400E-01 |
| Normal-VS-Unclassified PRCC |
1.640700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.972790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.986400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.735500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.760200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.440500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.017800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.596400E-01 |
| Normal-vs-N1 |
2.031200E-01 |
| Normal-vs-N2 |
1.778340E-02 |
| N0-vs-N1 |
8.198000E-01 |
| N0-vs-N2 |
3.109200E-01 |
| N1-vs-N2 |
1.001600E-01 |
|
|
